维普中文期刊产品整合服务
15篇 您的检索式:作者名="Skreb"
    题名 作者 年代 出处 被引量
1Suplementacija s antioksidansima u terapiji Graves-ove bolesti: u?inak na ekstracelularne antioksidativne parametre显示文摘VESNA BACIC VRCA FRANJO SKREB IVANA CEPELAK LJILJANA MAYER 2004Acta pharmaceutica2004,,2:1
2The effect of antioxi- dant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease 显示文摘Bacic-Vrca V Skreb F Cepelak I 2005Clin Chem Lab Med2005,43,4:1
3Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters显示文摘BacicVrca V Skreb F Cepelak I 2004Acta Pharmaceutica2004,54,2:1
4Antioxidants in patients with hyperthyroidism显示文摘Mayer L Romic' Z Skreb F 2004Clin Chem Lab Med2004,42,2:1
5Echographic thyroid changes in iodine deficiency and excess 显示文摘Horvatic G Skreb F Kuna S 1998European Journal of Ultrasound1998,,7:1
6Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters显示文摘BacicVrca V Skreb F Cepelak I 2004Acta Pharmaceutica2004,54,2:1
7Supplementation with antioxidants in the treatment of Graves′ disease; the effect on glutathione peroxidase activity and concentration of Selenium显示文摘Vrca VB Skreb F Cepelak I 2004Clin Chim Acta2004,341,12:1
8Supplementation with antioxidants in the treatment of Graves' disease:the effect on the extracellular antioxidative parameters显示文摘Bacic Vrca V Skreb F Cepelak I 2004Acta Pharm2004,54,2:1
9Antioxidant supplemen- tation and serum lipids in patients with Graves' disease: effect on LDL-cholesterol显示文摘Vrca VB Mayer L Skreb F 2012Acta Pharm2012,62,1:1
10Antioxidants in patients with hyperthyroidism显示文摘Mayer L Romic Z Skreb F 2004Clin Chem Lab Med2004,42,2:1
11Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium显示文摘Vrca VB Skreb F Cepelak I 2004Clin Chim Acta2004,341,12:1
12Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters显示文摘Vrca VB Skreb F Cepelak I 2004Acta Pharmaceutiea (Zagreb)2004,54,2:1
13Supplementation with antioxidants in the treatment of Graves' disease:the effect on the extracellular antioxidative parameters显示文摘Bacic Vrca V Skreb F Cepelak I 0,,:1
14Antioxidant supplementation and serum lipids in patients with Graves' disease:effect on LDL-cholesterol显示文摘Vrca VB Mayer L Skreb F 0,,:1
15Field evaluation of COVID-19 rapid antigen test:Are rapid antigen tests less reliable among the elderly?显示文摘BACKGROUND The global outbreak of coronavirus disease 2019(COVID-19)leads to the development of accessible and cost-effective rapid antigen-detection tests(RATs),as quick and accurate diagnosis is crucial to curb the pandemic.AIM To evaluate the Humasis COVID-19 Ag Test(Humasis Co.,Ltd.,Gyeonggi-do,Republic of Korea)in the diagnosis of severe acute respiratory syndrome coronavirus-2(SARS-CoV-2).METHODS This retrospective study was carried out at the Croatian Institute of Public Health and included patients with clinical symptoms of COVID-19 lasting no longer than 5 d prior to testing,whose nasopharyngeal swabs were primarily tested with RAT.Negative RAT samples underwent confirmatory real-time reverse transcription-polymerase chain reaction(RT-PCR).Diagnostic efficacy was determined compared to RT-PCR.The patients were divided into three age groups(<18,19-65,>65 years).Statistical analysis was performed with the significance level set at P<0.05.RESULTSIn total,2490 symptomatic patients were tested;953 samples were positive on RAT,and 1537 werenegative.All negative RAT samples were subjected to RT-PCR;266 samples were positive andmarked as false-negative results on RAT.The calculated negative predictive value as a measure ofRAT efficacy was 82.69%.The χ^(2) test and Kruskal-Wallis test showed a significant difference in theproportion of false negatives(P<0.001)and RT-PCR cycle(Ct)values for false-negative RATs(P=0.012)among the age groups.The young age group was significantly less likely to be falsenegative,whereas the false negatives from the elderly group experienced significantly lower Ctvalues than the other two age groups.CONCLUSIONEvaluated RAT demonstrated satisfactory performance with more reliable results in youngerpatients.Humasis COVID-19 Ag RAT is potentially a valuable tool in areas where access tomolecular methods is limited;however,RT-PCR remains a gold standard for SARS-CoV-2detection.Irena Tabain Djivo Cucevic Nikola Skreb Anna Mrzljak Ivana Ferencak Zeljka Hruskar Anita Misic Josipa Kuzle Ana Marija Skoda Hrvojka Jankovic Tatjana Vilibic-Cavlek 2022World Journal of Clinical Cases2022,10,19:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费